John P. Morris

10.2k total citations · 3 hit papers
36 papers, 6.6k citations indexed

About

John P. Morris is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, John P. Morris has authored 36 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 17 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in John P. Morris's work include Pancreatic and Hepatic Oncology Research (12 papers), Epigenetics and DNA Methylation (8 papers) and Pancreatic function and diabetes (7 papers). John P. Morris is often cited by papers focused on Pancreatic and Hepatic Oncology Research (12 papers), Epigenetics and DNA Methylation (8 papers) and Pancreatic function and diabetes (7 papers). John P. Morris collaborates with scholars based in United States, United Kingdom and Germany. John P. Morris's co-authors include Matthias Hebrok, A. Thomas Look, Sam C. Wang, Cheryll Sanchez-Irizarry, Lewis B. Silverman, Andrew P. Weng, Adolfo A. Ferrando, Jon C. Aster, Woojoong Lee and Stephen C. Blacklow and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

John P. Morris

36 papers receiving 6.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia

2004 2.0k citations Andrew P. Weng, Adolfo A. Ferrando et al. Science profile →
Identification of Sox9-Dependent Acinar-to-Ductal Reprogramming as the Principal Mechanism for Initiation of Pancreatic Ductal Adenocarcinoma

2012 472 citations Janel L. Kopp, Guido von Figura et al. Cancer Cell profile →
Mutant p53 Drives Pancreatic Cancer Metastasis through Cell-Autonomous PDGF Receptor β Signaling

2014 362 citations Susann Weissmueller, Eusebio Manchado et al. Cell profile →

Peers

Countries citing papers authored by John P. Morris

Since Specialization

Citations

This map shows the geographic impact of John P. Morris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John P. Morris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John P. Morris more than expected).

Fields of papers citing papers by John P. Morris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John P. Morris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John P. Morris. The network helps show where John P. Morris may publish in the future.

Co-authorship network of co-authors of John P. Morris

This figure shows the co-authorship network connecting the top 25 collaborators of John P. Morris. A scholar is included among the top collaborators of John P. Morris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John P. Morris. John P. Morris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Metabolic adaptations direct cell fate during tissue regeneration 2025 ·Nature ·Almudena Chaves Perez, Scott E. Millman, Sudha Janaki‐Raman, Yu-Jui Ho, Clemens Hinterleitner, Valentin J.A. Barthet, John P. Morris, Francisco M. Barriga, José Reyes, Aye Kyaw, H. Amalia Pasolli, Dana Pe’er, Craig B. Thompson, Lydia W.S. Finley, Justin R. Cross, Scott W. Lowe	3
2	MLL3 regulates the CDKN2A tumor suppressor locus in liver cancer 2023 ·eLife ·Changyu Zhu, Yadira M. Soto-Feliciano, John P. Morris, Chun‐Hao Huang, Richard P. Koche, Yu-Jui Ho, Ana Banito, Chun‐Wei Chen, Aditya Shroff, Sha Tian, Geulah Livshits, Chi-Chao Chen, Myles Fennell, Scott A. Armstrong, C. David Allis, Darjus F. Tschaharganeh, Scott W. Lowe	13
3	A preclinical platform for assessing antitumor effects and systemic toxicities of cancer drug targets 2022 ·Proceedings of the National Academy of Sciences ·(unknown), Chun‐Hao Huang, Francisco J. Sánchez‐Rivera, Margaret C. Kennedy, Darjus F. Tschaharganeh, John P. Morris, Antonella Montinaro, Kevin P. O’Rourke, Ana Banito, John E. Wilkinson, Chi-Chao Chen, Yu-Jui Ho, Lukas E. Dow, Sha Tian, Wei Luan, Elisa de Stanchina, Tinghu Zhang, Nathanael S. Gray, Henning Walczak, Scott W. Lowe	8
4	A biomedical open knowledge network harnesses the power of AI to understand deep human biology 2022 ·AI Magazine ·Sergio E. Baranzini, Katy Börner, John P. Morris, Charlotte Nelson, Karthik Soman, (unknown), Michael J. Keiser, Mark A. Musen, Roger Pearce, (unknown), Brett Smith, Bruce Herr, Boris Oskotsky, Angela Rizk‐Jackson, Katherine P. Rankin, Stephan Sanders, Riley Bove, Peter W. Rose, (unknown), Sui Huang	6
5	A gene–environment-induced epigenetic program initiates tumorigenesis 2021 ·Nature ·Direna Alonso‐Curbelo, Yu-Jui Ho, Cassandra Burdziak, Jesper L.V. Mååg, John P. Morris, Rohit Chandwani, Hsuan-An Chen, Kaloyan M. Tsanov, Francisco M. Barriga, Wei Luan, Nilgun Tasdemir, Geulah Livshits, Elham Azizi, Jaeyoung Chun, John E. Wilkinson, Linas Mažutis, Steven D. Leach, Richard P. Koche, Dana Pe’er, Scott W. Lowe	161
6	Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer 2020 ·Cell ·Marcus Ruscetti, John P. Morris, Riccardo Mezzadra, James Russell, Josef Leibold, Paul B. Romesser, Janelle Simon, Amanda Kulick, Yu-Jui Ho, Myles Fennell, Jinyang Li, Robert J. Norgard, John E. Wilkinson, Direna Alonso‐Curbelo, Ramya Sridharan, Daniel A. Heller, Elisa de Stanchina, Ben Z. Stanger, Charles J. Sherr, Scott W. Lowe	281
7	Vitamin B6 Addiction in Acute Myeloid Leukemia 2020 ·Cancer Cell ·Chi-Chao Chen, Bo Li, Scott E. Millman, Cynthia Chen, Xiang Li, John P. Morris, Allison Mayle, Yu-Jui Ho, Evangelia Loizou, Hui Liu, (unknown), Hardik Shah, Sara Violante, Justin R. Cross, Scott W. Lowe, Lingbo Zhang	55
8	Arid1a restrains Kras-dependent changes in acinar cell identity 2018 ·eLife ·Geulah Livshits, Direna Alonso‐Curbelo, John P. Morris, Richard P. Koche, Michael Saborowski, John E. Wilkinson, Scott W. Lowe	33
9	A modular and flexible ESC-based mouse model of pancreatic cancer 2014 ·Genes & Development ·Michael Saborowski, Anna Saborowski, John P. Morris, Benedikt Bosbach, Lukas E. Dow, Jerry Pelletier, David S. Klimstra, Scott W. Lowe	52
10	Mutant p53 Drives Pancreatic Cancer Metastasis through Cell-Autonomous PDGF Receptor β Signaling breakdown → 2014 ·Cell ·Susann Weissmueller, Eusebio Manchado, Michael Saborowski, John P. Morris, Elvin Wagenblast, Carrie Davis, Sung‐Hwan Moon, Neil T. Pfister, Darjus F. Tschaharganeh, Thomas Kitzing, Daniela E. Aust, Elke Markert, Jianmin Wu, Sean M. Grimmond, Christian Pilarsky, Carol Prives, Andrew V. Biankin, Scott W. Lowe	362
11	Canonical Wnt Signaling Is Required for Pancreatic Carcinogenesis 2013 ·Cancer Research ·Yaqing Zhang, John P. Morris, Wei Yan, Heather Schofield, Austin Gurney, Diane M. Simeone, Sarah E. Millar, Timothy Hoey, Matthias Hebrok, Marina Pasca di Magliano	152
12	Dormant Cancer Cells Contribute to Residual Disease in a Model of Reversible Pancreatic Cancer 2013 ·Cancer Research ·Wan-Chi Lin, Nirakar Rajbhandari, Chengbao Liu, Kazuhito Sakamoto, Qian Zhang, Aleata A. Triplett, Surinder K. Batra, René Opavský, Dean W. Felsher, Dominick J. DiMaio, Michael A. Hollingsworth, John P. Morris, Matthias Hebrok, Agnieszka K. Witkiewicz, Jonathan R. Brody, Hallgeir Rui, Kay‐Uwe Wagner	60
13	Nr5a2 maintains acinar cell differentiation and constrains oncogenic Kras-mediated pancreatic neoplastic initiation 2013 ·Gut ·Guido von Figura, John P. Morris, Christopher V.E. Wright, Matthias Hebrok	108
14	Bmi1 Is Required for Regeneration of the Exocrine Pancreas in Mice 2012 ·Gastroenterology ·Akihisa Fukuda, John P. Morris, Matthias Hebrok	31
15	Identification of Sox9-Dependent Acinar-to-Ductal Reprogramming as the Principal Mechanism for Initiation of Pancreatic Ductal Adenocarcinoma breakdown → 2012 ·Cancer Cell ·Janel L. Kopp, Guido von Figura, Erin Mayes, Fenfen Liu, Claire L. Dubois, John P. Morris, Fong Cheng Pan, Haruhiko Akiyama, Christopher V.E. Wright, Kristin C. Jensen, Matthias Hebrok, Maike Sander	472
16	Stat3 and MMP7 Contribute to Pancreatic Ductal Adenocarcinoma Initiation and Progression 2011 ·Cancer Cell ·Akihisa Fukuda, Sam C. Wang, John P. Morris, Alexandra E. Folias, Angela Liou, Grace Kim, Shizuo Akira, Kenneth M. Boucher, Matthew A. Firpo, Sean J. Mulvihill, Matthias Hebrok	400
17	KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma 2010 ·Nature reviews. Cancer ·John P. Morris, Sam C. Wang, Matthias Hebrok	430
18	Expanded RNA-binding activities of mammalian Argonaute 2 2009 ·Nucleic Acids Research ·Grace Tan, Barry G. Garchow, Xuhang Liu, Jennifer Yeung, John P. Morris, Trinna Cuellar, Michael T. McManus, Marianthi Kiriakidou	102
19	Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia breakdown → 2004 ·Science ·Andrew P. Weng, Adolfo A. Ferrando, Woojoong Lee, John P. Morris, Lewis B. Silverman, Cheryll Sanchez-Irizarry, Stephen C. Blacklow, A. Thomas Look, Jon C. Aster	2013
20	Zebrafish Sperm Cryopreservation 2004 ·Methods in cell biology ·Stéphane Berghmans, John P. Morris, John P. Kanki, A. Thomas Look	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact